Compare Bristol-Myers Squibb Co (BMY) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Realty Income Corp — how do they compare? Bristol-Myers Squibb Co trades at $63.57 (market cap $129.94B), while Realty Income Corp trades at $61.94 (market cap $58.56B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.2× Realty Income Corp's market cap, and Realty Income Corp pays the higher dividend (5.25%). Which is the better fit depends on your goals.
| BMY | O | |
|---|---|---|
Market Cap | $129.94B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $65.89 | $67.56 |
52-Week Low | $42.60 | $55.93 |
Enterprise Value | $163.92B | $89.19B |
Dividend Yield | 3.96% | 5.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
